CeriBell, Inc. (CBLL) vs Seaport Therapeutics, Inc. Common Stock (SPTX)

A side-by-side comparison of CeriBell, Inc. and Seaport Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
CeriBell, Inc. logo
CBLL
CeriBell, Inc.
$935M
$24.65HealthcareDelayed quote: Oct 6, 2026, 2:35 PM EDT
Seaport Therapeutics, Inc. Common Stock logo
SPTX
Seaport Therapeutics, Inc. Common Stock
$937M
$17.50HealthcareDelayed quote: Oct 6, 2026, 2:35 PM EDT

Total return — CBLL vs SPTX

growth of $100 · dividends reinvested · last 1y
CBLL +21.3% (+21.3%/yr)SPTX -6.8% (-6.8%/yr)CBLL compounded faster over this window
80100120140Start $100$121$93
CBLL SPTX

CBLL vs SPTX: by the numbers

  • •SPTX is the larger company ($937M vs $935M market cap).
  • •Both run net losses; SPTX's is the smaller (0.00% vs -64.73% net margin).

Metrics side by side

Valuation

MetricCBLLSPTX
P/S ratio9.17N/A
P/B ratio7.292.22

Profitability

MetricCBLLSPTX
Gross margin88.90%0.00%
Operating margin-68.62%0.00%
Net margin-64.73%0.00%
ROE-51.43%N/A
ROIC-46.54%-36.95%

Go deeper

Full CBLL analysisFull SPTX analysisInteractive comparison tool

Dig into the metrics

CeriBell ROESeaport Therapeutics, Inc. Common Stock ROECeriBell operating marginSeaport Therapeutics, Inc. Common Stock operating marginCeriBell revenue growthSeaport Therapeutics, Inc. Common Stock revenue growthCeriBell free cash flowSeaport Therapeutics, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.